Fineotex Chemical consolidated net profit up at Rs. 13.07 Cr
The company has reported total income of Rs.158.06 crores during the 9 months ended December 31, 2020.
The company has reported total income of Rs.158.06 crores during the 9 months ended December 31, 2020.
With these measures, cost savings of more than €200 million annually should be realized as of 2023.
With this 5000 ton-production increase, Kureha will further enhance its stable and efficient supply of differentiated and quality PPS resins
EBITDA for the quarter stood at Rs. 427 crore and Net Profit was at Rs. 169 crore. Our Core EBITDA margins stood at 31%.
Expects to integrate the new product portfolio within a short period of time
INOVYN will provide state of the art BICHLOR bipolar electrolysers for a new 33,000 square meter facility.
The plans for the new plant are part of the project “ABSolutely Circular”, which is supported by the EU LIFE programme
Investment to increase production capacity demonstrates company's commitment to regional customers and to meeting their growing needs
Selling prices increased by about 1.5%. Sales volumes decreased approximately 1.5% versus the prior year.
The said Industrial Plot is acquired under e-auction process held through Liquidator/IP appointed by Hon'ble NCLT, New Delhi
Till date, the company has been granted 83 patents globally.
The process for applying environment clearance and ordering of plant and machinery has started.
Air Liquide’s first contract with BASF in Yeosu was signed 20 years ago.
NEOS and the University of Oxford are launching a new world-leading institute to combat the growing global issue of antimicrobial resistance (AMR)
EBITDA and PAT for the quarter were both up 11% to Rs. 193 crores and Rs. 102 crores respectively.
Company has launched two new products in North America - Imron Elite ColorPLUS and Imron Elite Direct-to-Plastic basecoat
The company has reported total income of Rs.771.83 crores during the period ended December 31, 2020 as compared to Rs.774.46 crores during the period ended December 31, 2019.
Caregen’s highly potent synthetic peptides will be a complementary technology to the bioactives and other cosmetic solutions and ingredients offered by BASF’s personal care portfolio.
BASF sees adjusted earnings before interest and taxes rising to 1.1 billion euros ($1.3 billion) and sales climbing to 15.9 billion euros, up 8%, in the three months through December.
The EBITDA increased to Rs. 40.3 crores, up 41% YoY versus Rs. 28.7 crores during Q3 FY20.
Subscribe To Our Newsletter & Stay Updated